Abstract
Huang, Tailor, et al. show that neuroepithelial stem (NES) cells derived from normal induced pluripotent stem cells (iPSCs) provide a renewable human cell-based resource to evaluate genetic mutations in medulloblastoma. Misexpression of MYCN in both otherwise-normal NES cells and PTCH1+/− NES cells derived from patients with Gorlin syndrome each generated medulloblastoma in mice.
Original language | English |
---|---|
Pages (from-to) | 433-446.e7 |
Journal | Cell Stem Cell |
Volume | 25 |
Issue number | 3 |
DOIs | |
Publication status | Published - 5 Sept 2019 |
Externally published | Yes |
Keywords
- human pluripotent stem cells
- medulloblastoma
- neuroepithelial stem cells
- SHH